Drug profile · INN
thiopental sodium
PENTOTHAL
thiopental sodium (PENTOTHAL) is a gaba-a receptor; anion channel positive allosteric modulator. Route of administration: rectal. Current US regulatory status: approved.
Drug details — thiopental sodium
- US status
- approved
- Class
- —
- Route
- RECTAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
thiopental sodium (PENTOTHAL) is a gaba-a receptor; anion channel positive allosteric modulator. Route of administration: rectal. Current US regulatory status: approved.
Key facts
Mechanism of action
GABA-A receptor; anion channel positive allosteric modulator
Primary target: GABA-A receptor; anion channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is thiopental sodium?
thiopental sodium (PENTOTHAL) is a gaba-a receptor; anion channel positive allosteric modulator. Route of administration: rectal. Current US regulatory status: approved.
What is the brand name for thiopental sodium?
PENTOTHAL is a marketed brand name for thiopental sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of thiopental sodium?
thiopental sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.